KORU Medical Systems, Inc. (NASDAQ:KRMD) Shares Acquired by Jane Street Group LLC

Jane Street Group LLC increased its position in KORU Medical Systems, Inc. (NASDAQ:KRMD) by 67.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 68,923 shares of the company’s stock after buying an additional 27,664 shares during the quarter. Jane Street Group LLC owned about 0.15% of KORU Medical Systems worth $265,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Y Intercept Hong Kong Ltd acquired a new stake in shares of KORU Medical Systems in the fourth quarter valued at $104,000. Raymond James Financial Inc. acquired a new stake in shares of KORU Medical Systems in the fourth quarter valued at $118,000. Virtu Financial LLC acquired a new stake in shares of KORU Medical Systems in the fourth quarter valued at $73,000. Russell Investments Group Ltd. lifted its holdings in shares of KORU Medical Systems by 41,806.9% in the fourth quarter. Russell Investments Group Ltd. now owns 67,051 shares of the company’s stock valued at $258,000 after buying an additional 66,891 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of KORU Medical Systems by 11.2% in the fourth quarter. Northern Trust Corp now owns 79,175 shares of the company’s stock valued at $305,000 after buying an additional 7,967 shares during the period. Institutional investors and hedge funds own 58.60% of the company’s stock.

KORU Medical Systems Stock Performance

Shares of NASDAQ KRMD opened at $2.84 on Wednesday. The business’s 50-day moving average price is $2.63 and its two-hundred day moving average price is $3.40. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.99 and a quick ratio of 2.37. KORU Medical Systems, Inc. has a one year low of $1.86 and a one year high of $5.05. The company has a market capitalization of $131.04 million, a P/E ratio of -11.36 and a beta of 0.39.

KORU Medical Systems (NASDAQ:KRMD) last released its quarterly earnings results on Wednesday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.01). The company had revenue of $9.64 million for the quarter, compared to the consensus estimate of $8.86 million. KORU Medical Systems had a negative return on equity of 24.60% and a negative net margin of 37.42%. Analysts anticipate that KORU Medical Systems, Inc. will post -0.13 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

KRMD has been the topic of a number of recent analyst reports. Piper Sandler cut their target price on KORU Medical Systems from $4.50 to $3.50 and set a “neutral” rating on the stock in a research report on Thursday, May 8th. B. Riley raised KORU Medical Systems to a “strong-buy” rating in a research report on Thursday, March 13th. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $4.50.

KORU Medical Systems Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.